title: Severe neutropenia caused by recommended prophylactic doses of rifabutin.
authors.forename: G
authors.initials: G
authors.lastname: Apseloff
authors.forename: G
authors.initials: G
authors.lastname: Fluids
authors.forename: L
authors.initials: L
authors.lastname: LaBoy-Goral
authors.forename: E
authors.initials: E
authors.lastname: Kraut
authors.forename: J
authors.initials: J
authors.lastname: Vincent
mesh_terms: D000208:Acute Disease; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D017963:Azithromycin / Q000008:administration & dosage / Q000009:adverse effects; D017291:Clarithromycin / Q000008:administration & dosage / Q000009:adverse effects; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D009503:Neutropenia / Q000139:chemically induced*; D017828:Rifabutin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000900:Anti-Bacterial Agents; D017828:Rifabutin; D017963:Azithromycin; D017291:Clarithromycin